Large-scale testing (Phase 3)Study completedNCT00731679
What this trial is testing
Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)
Who this might be right for
Non-Constipation Irritable Bowel Syndrome
Bausch Health Americas, Inc. 623